Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
80.01
+7.45 (10.27%)
At close: Mar 9, 2026, 4:00 PM EDT
80.49
+0.48 (0.60%)
After-hours: Mar 9, 2026, 6:50 PM EDT
Lantheus Holdings Revenue
In the year 2025, Lantheus Holdings had annual revenue of $1.54B with 0.50% growth. Lantheus Holdings had revenue of $406.79M in the quarter ending December 31, 2025, with 4.01% growth.
Revenue (ttm)
$1.54B
Revenue Growth
+0.50%
P/S Ratio
3.32
Revenue / Employee
$1,292,212
Employees
1,193
Market Cap
5.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | 7.70M | 0.50% |
| Dec 31, 2024 | 1.53B | 237.48M | 18.32% |
| Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
| Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
| Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.27B |
| Amneal Pharmaceuticals | 3.02B |
| Hims & Hers Health | 2.35B |
| Alkermes | 1.48B |
| Phibro Animal Health | 1.46B |
| Prestige Consumer Healthcare | 1.10B |
| BioCryst Pharmaceuticals | 874.84M |
| Supernus Pharmaceuticals | 718.95M |
LNTH News
- 3 days ago - Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection - GlobeNewsWire
- 7 days ago - Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH - Business Wire
- 10 days ago - Lantheus Holdings, Inc. (LNTH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 25 days ago - Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time - GlobeNewsWire
- 2 months ago - Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies - GlobeNewsWire
- 3 months ago - Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH) - Newsfile Corp
- 4 months ago - The Bottom Fishing Club - Lantheus Holdings: Interesting Buy Momentum Supporting Price - Seeking Alpha